MarketPeel
Insider Trading Intelligence
MT

Marco Taglietti

AQST
DIRECTOR · AQUESTIVE THERAPEUTICS, INC. · CIK 0001408870
FILING MIX · LIFETIME94%/6%
BUYS
16
SELLS
1
TOTAL VALUE
$618.2K
COMPANIES
3
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
125,500
AVG SELL PX
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Marco Taglietti, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+18.77%+0.62%+18.16%+18.16%
14d2+50.00%+0.91%-1.92%+2.83%+2.83%
30d2+50.00%+0.84%+0.88%-0.04%-0.04%
60d2+50.00%+15.89%+0.09%+15.80%+15.80%
90d2+50.00%+17.12%+1.28%+15.84%+15.84%
180d2+50.00%+8.79%+2.68%+6.12%+6.12%
1y2+100.00%+25.67%+13.19%+12.47%+12.47%
2y2+0.00%-54.00%+16.48%-70.48%-70.48%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AQST · 50,500 shares · as of Jun 10, 2026
012,62525,25037,87550,50020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 1 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,50050,500Jun 10, 2026Jun 11, 2026View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,000$3.41$143.2K42,000Jun 11, 2025Jun 12, 2025View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
38,00038,000Jun 20, 2024Jun 24, 2024View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 21, 2023Jun 23, 2023View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Jun 22, 2022Jun 24, 2022View →
SCYX
SCYNEXIS INC
PURCHASE
Chief Executive Officer
75,000$3.00$225.0K272,068Apr 26, 2022Apr 28, 2022View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
75,00075,000Apr 26, 2022Apr 28, 2022View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
232,000232,000Feb 4, 2022Feb 8, 2022View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
87,200196,968Feb 4, 2022Feb 8, 2022View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00020,000Jun 15, 2021Jun 17, 2021View →
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,50028,500Mar 11, 2021Mar 15, 2021View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
170,000170,000Jan 29, 2021Feb 2, 2021View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
20,00020,000Dec 21, 2020Dec 23, 2020View →
SCYX
SCYNEXIS INC
PURCHASE
Chief Executive Officer
40,000$6.25$250.0K109,668Dec 21, 2020Dec 23, 2020View →
DCTH
DELCATH SYSTEMS, INC.
PURCHASE
6,0006,000May 8, 2020May 8, 2020View →
DCTH
DELCATH SYSTEMS, INC.
SALE
600May 8, 2020May 8, 2020View →
SCYX
SCYNEXIS INC
PURCHASEGRANT
Stock grant
900,000900,000Jan 31, 2020Feb 4, 2020View →
Other insiders · AQST
Loading peer insiders…
About this filer
CIK 0001408870
ROLE
Director
PRIMARY
AQST
COMPANIES
3
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001408870DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback